Literature DB >> 21431307

Prevalence of factor V Leiden in south Tunisian blood donors.

Lobna Maalej1, Basma Hadjkacem, Ikram Ben Amor, Mariem Smaoui, Ali Gargouri, Jalel Gargouri.   

Abstract

Venous thrombosis (VT) is a common disease with multifactorial pathogenesis. Factor V Leiden mutation (G1691A) (FVL) is the most common risk factor in venous thrombosis. The prevalence of FVL varies according to geography and ethnicity. Hence, in several countries there is a difference in the frequency of this mutation between the southern, central and north. In Tunisia, no data is available about prevalence of FVL mutation by geographical origin. For this reason, we sought the prevalence of FVL mutation in blood donor of south Tunisia population. FVL has been detected by APCR-test and confirmed by PCR-RFLP and sequencing. Two hundred fifty blood donors, different in age and sex were included in this study to determine the prevalence of FVL in blood donors. FVL mutation was found in 13.6% of the studied population. Thirty-one were heterozygous and three persons were homozygous with a rate of 12.4 and 1.2%, respectively. In conclusion, FVL mutation is very common in south Tunisian population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21431307     DOI: 10.1007/s11239-011-0582-9

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  19 in total

1.  High prevalence of factor V mutation (Leiden) in the Eastern Mediterranean.

Authors:  N Irani-Hakime; H Tamim; G Elias; R R Finan; J L Daccache; W Y Almawi
Journal:  Clin Chem       Date:  2000-01       Impact factor: 8.327

2.  Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population.

Authors:  Florence Mathonnet; Sellama Nadifi; Valérie Serazin-Leroy; Mbarka Dakouane; Yves Giudicelli
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249

3.  Prevalence of factor V Leiden (G1691A) and prothrombin (G20210A) among Kurdish population from Western Iran.

Authors:  Zohreh Rahimi; Asad Vaisi-Raygani; Hadi Mozafari; Hadi Kharrazi; Mansour Rezaei; Ronald L Nagel
Journal:  J Thromb Thrombolysis       Date:  2007-08-14       Impact factor: 2.300

4.  Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.

Authors:  Elisabeth Mazoyer; Laurent Ripoll; René Gueguen; Laurence Tiret; Jean-Philippe Collet; Claire Bal dit Sollier; Jacqueline Roussi; Ludovic Drouet
Journal:  Blood Coagul Fibrinolysis       Date:  2009-10       Impact factor: 1.276

5.  Prevalence of factor V leiden mutation in patients with thrombosis in Tunisia.

Authors:  A Ajem; A Slama; F B H Slama; T Mehjoub
Journal:  East Mediterr Health J       Date:  2009 Nov-Dec       Impact factor: 1.628

6.  Prevalence of factor V Leiden in a Canadian blood donor population.

Authors:  D H Lee; P A Henderson; M A Blajchman
Journal:  CMAJ       Date:  1996-08-01       Impact factor: 8.262

7.  High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.

Authors:  Mohamed Baba-Ahmed; Grégoire Le Gal; Francis Couturaud; Karine Lacut; Emmanuel Oger; Christophe Leroyer
Journal:  Thromb Haemost       Date:  2007-02       Impact factor: 5.249

8.  Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Authors:  C Y Vossen; J Conard; J Fontcuberta; M Makris; F J M VAN DER Meer; I Pabinger; G Palareti; F E Preston; I Scharrer; J C Souto; P Svensson; I D Walker; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

9.  Factor V Leiden mutation in venous thrombosis in southeast Turkey.

Authors:  Sevgi Kalkanli; Orhan Ayyildiz; Naci Tiftik; Sabri Batun; Abdurrahman Isikdogan; Hakan Ince; Selahaddin Tekes; Ekrem Muftuoglu
Journal:  Angiology       Date:  2006 Mar-Apr       Impact factor: 3.619

Review 10.  Activated protein C resistance and factor V Leiden: a review.

Authors:  Adam Rosendorff; David M Dorfman
Journal:  Arch Pathol Lab Med       Date:  2007-06       Impact factor: 5.534

View more
  4 in total

Review 1.  Utility of testing for factor V Leiden.

Authors:  Massimo Franchini
Journal:  Blood Transfus       Date:  2012-07       Impact factor: 3.443

2.  Prevalence of positive factor V Leiden and prothrombin mutations in samples tested for thrombophilia in Saudi Arabia.

Authors:  Fatimah Madkhaly; Abdulaziz Alshaikh; Hala Aba Alkhail; Randa Alnounou; Tarek Owaidah
Journal:  Am J Blood Res       Date:  2021-06-15

3.  Epidemiology of activated protein C resistance and factor v leiden mutation in the mediterranean region.

Authors:  Mehrez M Jadaon
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-09-08       Impact factor: 2.576

4.  Etiology of Recurrent Pregnancy Loss in Saudi Females.

Authors:  Ahlam A Al-Ghamdi; Sawsan F Makhashen
Journal:  Saudi J Med Med Sci       Date:  2016-08-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.